Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 1:14 AM
NCT ID:
NCT02321293
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed or patients on treatment for histologically confirmed advanced EGFR-mutant NSCLC defined as unresectable stage 3A, stage 3B or stage 4.
* The EGFR mutation analysis must be performed prior to enrolment into the trial (i.e., before a patient is consented). Any EGFR mutation-positive result must be documented and the analysis for the mutation will be performed using the JGH local testing methodology.
* Receiving concurrent EGFR-TKI therapy.
* Eastern Cooperative Oncology Group (ECOG) Performance Score 0-3
Exclusion Criteria:
* Symptomatic brain metastases.
* Patients who are receiving any other investigational agents.
* Patients using other non-vitamin or mineral regular natural health product, which includes Chinese Herbs.
* Incapacity to understand and sign a written informed consent document in English/French.
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02321293
Study Brief:
Protocol Section:
NCT02321293